Control of ketogenesis from amino acids. IV. Tissue specificity in oxidation of leucine, tyrosine, and lysine.
In vitro and in vivo studies were made on the tissue specificity of oxidation of the ketogenic amino acids, leucine, tyrosine, and lysine. In in vitro studies the abilities of slices of various tissues of rats to form 14CO2 from 14C-amino acids were examined. With liver, but not kidney slices, addition of alpha-ketoglutarate was required for the maximum activities with these amino acids. Among the various tissues tested, kidney had the highest activity for lysine oxidation, followed by liver; other tissues showed very low activity. Kidney also had the highest activity for leucine oxidation, followed by diaphragm; liver and adipose tissue had lower activities. Liver had the highest activity for tyrosine oxidation, but kidney also showed considerable activity; other tissues had negligible activity. In in vivo studies the blood flow through the liver or kidney was stopped by ligation of the blood vessels. Then labeled amino acids were injected and recovery of radioactivity in respiratory 14CO2 was measured. In contrast to results with slices, no difference was found in the respiratory 14CO2 when the renal blood vessels were or were not ligated. On the contrary ligation of the hepatic vessels suppressed the oxidations of lysine and tyrosine completely and that of leucine partially. Thus in vivo, lysine and tyrosine seem to be metabolized mainly in the liver, whereas leucine is metabolized mostly in extrahepatic tissues and partly in liver. Use of tissue slices seems to be of only limited value in elucidating the metabolisms of these amino acids.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D003964:Diaphragm / Q000378:metabolism; D007656:Ketoglutaric Acids / Q000494:pharmacology; D007657:Ketone Bodies / Q000096:biosynthesis*; D007668:Kidney / Q000098:blood supply / Q000378:metabolism*; D007930:Leucine / Q000378:metabolism*; D008026:Ligation; D008099:Liver / Q000378:metabolism*; D008102:Liver Circulation; D008239:Lysine / Q000378:metabolism*; D008293:Malates / Q000494:pharmacology; D008297:Male; D051381:Rats; D013386:Succinates / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism*
D007656:Ketoglutaric Acids; D007657:Ketone Bodies; D008293:Malates; D013386:Succinates; D014443:Tyrosine; D007930:Leucine; D008239:Lysine